ANI Pharmaceuticals, Inc. (ANIP)

Nasdaq Health Care Pharmaceuticals S&P SmallCap 600

$67.41

-2.21 (-3.17%)

Close of Nov 06, 2026 · end-of-day data

Source: ANI Pharmaceuticals, Inc.'s 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 06, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$128.62M	$176.84M	$201.58M	$206.55M	$208.47M	$216.14M	$316.38M	$486.82M	$614.38M	$883.37M
Cost of revenue	$48.78M	$79.03M	$73.02M	$63.15M	$87.16M	$100.61M	$138.78M	$181.51M	$250.21M	$341.31M
Gross profit	$79.84M	$97.81M	$128.55M	$143.39M	$121.32M	$115.53M	$177.60M	$305.30M	$364.17M	$542.06M
Research & development	$2.91M	$9.07M	$15.39M	$19.81M	$16.00M	$11.37M	$22.32M	$34.29M	$44.58M	$51.66M
Selling, general & admin	$27.83M	$31.58M	$44.06M	$55.84M	$64.99M	$84.29M	$124.04M	$161.70M	$249.64M	$317.75M
Operating income	$20.08M	$28.33M	$35.36M	$16.35M	-$16.02M	-$39.79M	-$35.28M	$46.97M	$584.00K	$111.09M
Interest expense	$11.29M	$11.32M	$14.91M	$13.47M	$9.48M	$11.95M	$28.51M	$35.63M	$33.63M	$32.56M
Pre-tax income	$8.68M	$16.35M	$20.05M	$3.16M	-$25.96M	-$56.06M	-$62.66M	$19.87M	-$22.21M	$95.79M
Income tax	$4.74M	$17.43M	$4.56M	-$2.94M	-$3.41M	-$13.46M	-$14.77M	$1.09M	-$3.69M	$17.45M
Net income	$3.93M	-$1.08M	$15.49M	$6.09M	-$22.55M	-$42.60M	-$47.90M	$18.78M	-$18.52M	$78.34M
EBITDA	$42.42M	$56.26M	$69.10M	$60.96M	$28.62M	$7.46M	$21.69M	$106.76M	$68.31M	$202.51M
EPS (basic)	$0.34	$-0.09	$1.31	$0.51	$-1.88	$-3.40	$-3.05	$0.86	$-1.04	$3.50
EPS (diluted)	$0.34	$-0.09	$1.30	$0.50	$-1.88	$-3.40	$-3.05	$0.85	$-1.04	$3.32
Diluted shares	11.57M	11.55M	11.77M	12.04M	11.96M	12.60M	16.26M	18.19M	19.32M	21.23M
Gross margin	62.1%	55.3%	63.8%	69.4%	58.2%	53.5%	56.1%	62.7%	59.3%	61.4%
Operating margin	15.6%	16.0%	17.5%	7.9%	-7.7%	-18.4%	-11.2%	9.6%	0.1%	12.6%
Net margin	3.1%	-0.6%	7.7%	3.0%	-10.8%	-19.7%	-15.1%	3.9%	-3.0%	8.9%

Balance sheet

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash & equivalents	$27.36M	$31.14M	$43.01M	$62.33M	$7.86M	$100.30M	$48.23M	$221.12M	$144.86M	$285.58M
Receivables	$45.90M	$58.79M	$64.84M	$72.13M	$95.79M	$128.53M	$165.44M	$162.08M	$221.73M	$281.08M
Inventory	$26.18M	$37.73M	$40.50M	$48.16M	$60.80M	$81.69M	$105.36M	$111.20M	$136.78M	$143.07M
Total current assets	$103.01M	$131.60M	$152.88M	$187.69M	$170.32M	$321.77M	$344.26M	$519.82M	$528.46M	$753.12M
Goodwill	$1.84M	$1.84M	$3.58M	$3.58M	$3.58M	$27.89M	$28.22M	$28.22M	$59.99M	$62.48M
Total assets	$322.86M	$412.14M	$430.60M	$456.79M	$461.19M	$771.60M	$760.09M	$904.42M	$1.28B	$1.44B
Total current liabilities	$31.95M	$39.23M	$165.55M	$61.68M	$78.56M	$87.54M	$99.44M	$145.48M	$194.45M	$278.11M
Short-term debt	$0	$3.35M	$3.26M	$9.94M	$13.24M	$850.00K	$850.00K	$850.00K	$9.17M	$17.27M
Long-term debt	$0	$69.95M	$67.30M	$175.81M	$172.44M	$286.52M	$285.67M	$284.82M	$309.11M	$291.84M
Total debt	$0	$73.30M	$70.55M	$185.75M	$185.69M	$287.37M	$286.52M	$285.67M	$318.28M	$309.11M
Total liabilities	$153.22M	$237.38M	$233.34M	$244.00M	$265.49M	$412.86M	$421.55M	$446.82M	$855.94M	$899.65M
Shareholders' equity	$169.65M	$174.76M	$197.26M	$212.79M	$195.70M	$333.89M	$313.69M	$432.75M	$403.68M	$540.72M

Cash flow

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Operating cash flow	$27.47M	$39.42M	$67.07M	$45.63M	$15.27M	$3.32M	-$31.20M	$118.96M	$64.02M	$185.22M
Capital expenditures	$4.57M	$10.37M	$5.74M	$6.63M	$6.13M	$2.56M	$8.88M	$8.87M	$16.24M	$13.84M
Free cash flow	$22.91M	$29.05M	$61.33M	$39.00M	$9.13M	$765.00K	-$40.08M	$110.09M	$47.78M	$171.39M
Investing cash flow	-$149.06M	-$107.99M	-$27.38M	-$27.55M	-$68.32M	-$105.48M	-$15.74M	-$18.51M	-$404.72M	-$34.32M
Financing cash flow	-$729.00K	$72.36M	-$27.82M	$1.25M	-$1.44M	$194.59M	-$5.13M	$67.44M	$264.94M	-$9.94M
Dividends paid	—	—	—	$0	$0	$190.00K	$1.62M	$1.62M	$1.62M	$1.16M
Share buybacks	$2.50M	$0	$0	$1.03M	$1.52M	$890.00K	$1.96M	$4.99M	$10.96M	$12.21M
Stock-based compensation	$6.07M	$6.09M	$6.78M	$9.22M	$12.94M	$10.49M	$14.60M	$20.65M	$29.34M	$37.93M
Depreciation & amortization	$22.34M	$27.93M	$33.74M	$44.61M	$44.64M	$47.25M	$56.97M	$59.79M	$67.73M	$91.42M

Income statement

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Revenue	$131.65M	$137.43M	$138.04M	$148.33M	$190.57M	$197.12M	$211.37M	$227.81M	$247.06M	$237.46M	$266.04M	$290.78M
Cost of revenue	$53.42M	$49.16M	$57.70M	$63.08M	$80.28M	$73.04M	$74.61M	$93.39M	$100.27M	$93.58M	$100.16M	$111.53M
Gross profit	$78.23M	$88.27M	$80.34M	$85.26M	$110.29M	$124.08M	$136.76M	$134.42M	$146.79M	$143.88M	$165.89M	$179.25M
Research & development	$9.87M	$10.51M	$7.30M	$10.13M	$16.65M	$10.56M	$16.54M	$12.30M	$12.26M	$10.60M	$14.75M	$13.00M
Selling, general & admin	$44.46M	$48.02M	$52.82M	$79.08M	$69.72M	$76.53M	$81.77M	$76.66M	$82.79M	$73.66M	$91.66M	$94.86M
Operating income	$6.73M	$20.31M	$5.17M	-$20.52M	-$4.38M	$26.19M	$13.89M	$36.24M	$34.77M	$38.89M	$40.46M	$52.37M
Interest expense	$11.47M	$9.10M	$9.07M	$6.66M	$8.80M	$8.11M	$8.22M	$8.28M	$7.96M	$7.55M	$7.50M	$7.59M
Pre-tax income	$947.00K	$25.34M	-$2.29M	-$31.50M	-$13.76M	$19.99M	$10.53M	$33.80M	$31.48M	$40.22M	$37.10M	$49.04M
Income tax	-$208.00K	$7.13M	$0	-$7.33M	-$3.49M	$4.31M	$1.98M	$7.18M	$3.99M	$10.73M	$12.39M	$13.89M
Net income	$1.16M	$18.21M	-$2.29M	-$24.17M	-$10.28M	$15.68M	$8.55M	$26.62M	$27.49M	$29.49M	$24.71M	$35.15M
EBITDA	$21.92M	$35.00M	$19.87M	-$4.77M	$18.22M	$49.09M	$37.17M	$58.87M	$57.38M	$59.81M	$60.10M	$71.92M
EPS (basic)	$0.02	$0.84	$-0.14	$-1.27	$-0.55	$0.70	$0.37	$1.19	$1.24	$1.31	$1.09	$1.54
EPS (diluted)	$0.02	$0.82	$-0.14	$-1.27	$-0.55	$0.69	$0.36	$1.13	$1.17	$1.28	$1.05	$1.51
Diluted shares	371.00K	19.42M	19.32M	19.40M	43.00K	20.05M	20.31M	21.09M	317.00K	21.54M	21.91M	21.68M
Gross margin	59.4%	64.2%	58.2%	57.5%	57.9%	62.9%	64.7%	59.0%	59.4%	60.6%	62.4%	61.6%
Operating margin	5.1%	14.8%	3.7%	-13.8%	-2.3%	13.3%	6.6%	15.9%	14.1%	16.4%	15.2%	18.0%
Net margin	0.9%	13.2%	-1.7%	-16.3%	-5.4%	8.0%	4.0%	11.7%	11.1%	12.4%	9.3%	12.1%

Balance sheet

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Cash & equivalents	$221.12M	$228.60M	$240.11M	$144.98M	$144.86M	$149.80M	$217.83M	$262.61M	$285.58M	$311.18M	$360.21M	$420.76M
Receivables	$162.08M	$172.42M	$166.09M	$196.36M	$221.73M	$220.33M	$225.65M	$252.62M	$281.08M	$255.43M	$274.47M	$304.45M
Inventory	$111.20M	$113.84M	$125.45M	$148.04M	$136.78M	$137.41M	$138.31M	$146.47M	$143.07M	$143.47M	$143.15M	$136.41M
Total current assets	$519.82M	$540.56M	$555.46M	$521.30M	$528.46M	$536.29M	$602.63M	$698.40M	$753.12M	$747.08M	$825.43M	$902.82M
Goodwill	$28.22M	$28.22M	$28.22M	$60.43M	$59.99M	$60.66M	$60.53M	$62.48M	$62.48M	$62.48M	$62.48M	$62.48M
Total assets	$904.42M	$914.52M	$920.75M	$1.29B	$1.28B	$1.29B	$1.34B	$1.41B	$1.44B	$1.42B	$1.49B	$1.57B
Total current liabilities	$145.48M	$136.89M	$139.98M	$189.93M	$194.45M	$201.81M	$236.84M	$270.56M	$278.11M	$239.51M	$283.65M	$328.72M
Short-term debt	$850.00K	$850.00K	$850.00K	$7.15M	$9.17M	$11.19M	$13.22M	$15.24M	$17.27M	$19.30M	$21.33M	$23.36M
Long-term debt	$284.82M	$284.61M	$284.39M	$312.92M	$309.11M	$305.29M	$301.48M	$297.68M	$291.84M	$286.00M	$280.15M	$274.31M
Total debt	$285.67M	$285.46M	$285.24M	$320.07M	$318.28M	$316.49M	$314.70M	$312.92M	$309.11M	$305.29M	$301.48M	$297.68M
Total liabilities	$446.82M	$437.71M	$440.14M	$856.58M	$855.94M	$848.96M	$881.39M	$902.34M	$899.65M	$859.67M	$896.90M	$930.55M
Shareholders' equity	$432.75M	$451.96M	$455.76M	$405.95M	$403.68M	$418.62M	$436.76M	$505.82M	$540.72M	$562.30M	$597.21M	$637.11M

Cash flow

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Operating cash flow	$44.74M	$18.27M	$17.41M	$12.47M	$15.86M	$34.99M	$75.81M	$44.05M	$30.37M	$58.38M	$56.67M	$83.79M
Capital expenditures	$2.28M	$4.58M	$4.45M	$4.81M	$2.39M	$2.47M	$4.01M	$6.10M	$1.24M	$6.07M	$3.05M	$13.50M
Free cash flow	$42.46M	$13.69M	$12.96M	$7.66M	$13.47M	$32.52M	$71.80M	$37.95M	$29.12M	$52.30M	$53.62M	$70.28M
Investing cash flow	-$4.78M	$8.93M	-$4.45M	-$398.52M	-$10.68M	-$19.85M	-$6.91M	-$6.16M	-$1.40M	-$11.32M	-$3.05M	-$13.50M
Financing cash flow	-$11.92M	-$19.73M	-$1.45M	$291.03M	-$4.91M	-$9.91M	-$1.75M	$6.34M	-$4.64M	-$21.62M	-$4.65M	-$9.83M
Dividends paid	$406.00K	$406.00K	$407.00K	$406.00K	$406.00K	$406.00K	$407.00K	$344.00K	$0	$0	$0	$0
Share buybacks	$231.00K	$8.66M	$1.30M	$680.00K	$318.00K	$10.00M	$551.00K	-$10.55M	$12.21M	$19.75M	$813.00K	-$13.58M
Stock-based compensation	$5.62M	$6.93M	$7.86M	$7.49M	$7.06M	$8.87M	$9.60M	$9.69M	$9.77M	$10.19M	$11.41M	$11.63M
Depreciation & amortization	$15.19M	$14.69M	$14.70M	$15.75M	$22.60M	$22.89M	$23.28M	$22.63M	$22.61M	$20.92M	$19.64M	$19.55M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.